Literature DB >> 12900357

Rituximab-associated immune myelopathy.

Theodora Papadaki, Kostas Stamatopoulos, Achilles Anagnostopoulos, Athanasios Fassas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12900357     DOI： 10.1182/blood-2003-05-1532

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

Review 1.  The role of rituximab in autologous and allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.

Authors:  Elizabeth Naparstek
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

Review 2.  Rituximab-associated neutropenia.

Authors:  Kieron Dunleavy; Kevin Tay; Wyndham H Wilson
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

Review 3.  Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.

Authors:  Brian A Baldo
Journal:  Oncoimmunology       Date:  2013-10-17       Impact factor: 8.110

4.  Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone.

Authors:  Evgeniy Evdoshenko; Alexey Maslyanskiy; Sergey Lapin; Leonid Zaslavsky; Ruth Dobson; Areg Totolian; Alexander Skoromets; Amit Bar-Or
Journal:  ISRN Neurol       Date:  2013-09-10

5.  Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry.

Authors:  J H Salmon; P Cacoub; B Combe; J Sibilia; B Pallot-Prades; O Fain; A Cantagrel; M Dougados; E Andres; O Meyer; P Carli; E Pertuiset; I Pane; F Maurier; P Ravaud; X Mariette; J E Gottenberg
Journal:  RMD Open       Date:  2015-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.